Previous studies have demonstrated the association of elevated FOXR2 expression with poor prognosis in some cancers.10–12 However, whether FOXR2 overexpression has implications for therapeutic responses and clinical outcomes in specific CNS tumor types remains unknown. Here, FOXR2 is linked to central nervous system neoplasm.